login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
DYNAVAX TECHNOLOGIES CORP (DVAX) Stock News
USA
- NASDAQ:DVAX -
US2681582019
-
Common Stock
10.3
USD
+0.25 (+2.49%)
Last: 11/5/2025, 8:00:02 PM
10.2799
USD
-0.02 (-0.2%)
After Hours:
11/5/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
DVAX Latest News, Press Relases and Analysis
All
Press Releases
9 hours ago - By: Zacks Investment Research
- Mentions:
IOVA
Dynavax Technologies (DVAX) Surpasses Q3 Earnings Estimates
11 hours ago - By: Dynavax Technologies
- Mentions:
VXRT
Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program
11 hours ago - By: Dynavax Technologies
- Mentions:
VXRT
Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program
20 hours ago - By: Benzinga
- Mentions:
TECH
INSE
GEF
SKYT
...
Earnings Scheduled For November 5, 2025
a day ago - By: Zacks Investment Research
- Mentions:
QGEN
Qiagen (QGEN) Q3 Earnings and Revenues Surpass Estimates
2 days ago - By: Zacks Investment Research
- Mentions:
NUVB
Nuvation Bio Inc. (NUVB) Reports Q3 Loss, Tops Revenue Estimates
3 months ago - By: Stocktwits
- Mentions:
PKW
IWMW
Dynavax’s Experimental Shingles Vaccine Shows Positive Results In Study: Retail Expects Stock Rally To Continue Into Friday
3 months ago - By: Dynavax Technologies
Dynavax Reports Second Quarter 2025 Financial Results
14 days ago - By: Dynavax Technologies
Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025
15 days ago - By: Dynavax Technologies
Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial
a month ago - By: Benzinga
- Mentions:
NVAX
GSK
MRK
PFE
...
Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough'
5 months ago - By: Dynavax Technologies
Dynavax Comments on Glass Lewis Recommendation
2 months ago - By: Dynavax Technologies
Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference
3 months ago - By: Dynavax Technologies
Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile
3 months ago - By: The Motley Fool
Dynavax (DVAX) Q2 Revenue Jumps 29%
3 months ago - By: Zacks Investment Research
- Mentions:
IMTX
Dynavax Technologies (DVAX) Q2 Earnings and Revenues Beat Estimates
3 months ago - By: Zacks Investment Research
- Mentions:
PTGX
Protagonist Therapeutics (PTGX) Reports Q2 Loss, Lags Revenue Estimates
3 months ago - By: Dynavax Technologies
Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025
4 months ago - By: Yahoo Finance
- Mentions:
BCRX
Citizens JMP Reiterates a Buy Rating on Dynavax Technologies (DVAX) With a Price Target of $31
5 months ago - By: Dynavax Technologies
Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting
5 months ago - By: Deep Track Capital, LP
Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom
5 months ago - By: Dynavax Technologies
Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting
5 months ago - By: Deep Track Capital, LP
Glass Lewis Recommends Shareholders Support Deep Track’s Case for Board Change at Dynavax Technologies
5 months ago - By: Dynavax Technologies
Dynavax to Present at William Blair's 45th Annual Growth Stock Conference
6 months ago - By: Deep Track Capital, LP
Deep Track Capital Comments on ISS Recommendation
6 months ago - By: Dynavax Technologies
Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees
6 months ago - By: Deep Track Capital, LP
Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting
6 months ago - By: Dynavax Technologies
Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value
6 months ago - By: Zacks Investment Research
Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why
6 months ago - By: Dynavax Technologies
Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum
Please enable JavaScript to continue using this application.